Judith Heimbürger

Expertise Judith Advises Experience Highlights Career History

Partner

Life Sciences, IP & Commercial

+49 (0) 30 220 131 000 +49 (0) 162 234 40 00
Accolades

Expertise

Judith Heimbürger is an experienced lawyer specialising in advising clients in the life sciences sector.

She works with national and international companies as well as investors across pharmaceuticals, medical cannabis, medical devices, biotechnology and diagnostics, supporting them throughout the entire product and business development lifecycle.

Her clients particularly value her expertise in drafting and negotiating complex agreements, including cross-border supply and licensing arrangements (especially relating to patents and know-how), research and development agreements, collaboration and supply agreements, as well as contracts for clinical trials.

Judith also has significant experience advising on and leading cross-border M&A transactions, joint ventures and strategic partnerships in the life sciences sector. In addition, she advises on compliance matters, pharmaceutical advertising law, collaborations with physicians and pharmacists, and a wide range of regulatory issues relating to medical cannabis, medicinal products and medical devices.

A further key focus of her practice is legal advice in the field of medical cannabis, in particular CBD products – from regulatory matters and contract reviews through to M&A transactions.

Judith Advises

  • National and international companies in the life sciences sector, from start-ups to listed
    companies, in particular in the fields of pharmaceuticals, diagnostics, medical devices and biotechnology as well as investors in this field
  • Pharmacists and doctors, in particular on professional law issues when practicing via online platforms

Experience Highlights

  • High Tide Inc.: Comprehensive legal support on the signing of an investment agreement for the acquisition of a 51% stake in Remexian Pharma GmbH, one of Germany’s leading importers and wholesalers of medical cannabis.
  • German medium-sized API manufacturer: Legal advice and support in the negotiation of complex agreement structures, such as worldwide supply and license agreements with different partners
  • Canopy Growth Corp.: Advising a subsidiary of one of the leading Canadian medical cannabis suppliers on the acquisition of the German inhaler manufacturer Storz & Bickel GmbH & Co. KG for €135 million
  • Canadian medical cannabis supplier: Advising on the conclusion of a joint venture agreement with a German pharmaceutical wholesaler.
  • Large US medical devices manufacturer: Advising on CE marking, reclassification and other regulatory issues
  • Large US medical devices manufacturer: Advising on compliance issues in the context of clinical trials of medical devices.
  • International biotechnology company: Advising on several agreements (agreement on contract research, supply agreement)
  • German affiliate of a large international pharmaceutical company: Advising on various matters (e.g. supply and storage agreements)
  • A spin-off from a German university: Advising on various agreements (e.g., confidentiality and material transfer agreements, cooperation agreements) as well as issues concerning the German law on employees’ inventions
  • A German biotechnology company: Advising on a cooperation agreement concerning conducting a non-commercial clinical trial
  • Leading German medical cannabis manufacturer: Longstanding support in compliance and regulatory matters, contract reviews, as well as assessment of innovative business models, collaborations and marketing initiatives.

Career History

Previous Experience

  • 10/2023–12/2024 (from 03/2023): Counsel, Dentons Europe (Germany) GmbH & Co. KG
  • 04/2015–09/2023: Senior Associate, Dentons Europe LLP
  • 08/2012–03/2015: Associate, Salans LLP, later Salans SNR Denton LLP
  • 02/2012–07/2012 (until and including 02/2013): Trainee, Salans LLP

Memberships

  • German Bar Association (Deutscher Anwaltsverein (DAV))
  • Frankfurt Bar Association (Frankfurter Anwaltsverein e.V.)
  • INCBA (International Cannabis Bar Association)

Education

  • University of Bayreuth (legal studies with an additional qualification in economics (Wirtschaftsjuristin (Univ. Bayreuth))
  • Qualification as Business Mediator (Wirtschaftsmediatorin (CVM))

Awards

Publications

  • “Market Access for North American Operators: Opportunities, Uncertainties and IP Protection“, The Legal Industry Reviews Germany, Vol.11 (author), June 2026
  • “Medical Cannabis at the Crossroads: Expecting a Major Setback for Digital Patient Care?“, The Legal Industry Reviews Germany, Vol.10 (author), March 2026
  • “Amendments to the MedCanG: The End of Telemedicine Platforms and Mail-Order Pharmacies?“, The Legal Industry Reviews Germany, Vol.9 (co-author), November 2025
  • “GMP-washing – A Harmless Loophole or an Underestimated Legal Risk?’, The Legal Industry Reviews Germany, Vol.8 (co-author), July 2025
  • “The ‘Second Pillar’ of Cannabis Legalization – A Mystery”, The Legal Industry Reviews Germany, Edition 7 (co-author), February 2025
  • “Current Case Law on Treatment Platforms for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 6 (co-author), November 2024
  • “Online Platforms for Medical Cannabis Treatment and Legal Pitfalls”, The Legal Industry Reviews Germany, Edition 4 (co-author), February 2024
  • “Draft Bill German Cannabis Law – Consequences for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 2 (co-author), September 2023
  • “Neuer Vorstoß zur Bekämpfung der Korruption im Gesundheitswesen”, Science4Life (co-author), 2015
  • “Auftragsforschung – Zu welchem Preis? ”, GoingPublic Magazin – Special “Biotechnologie” 2015 (co-author), 2015
  • “Bekämpfung von Korruption im Gesundheitswesen”, ZRFC 3/15, (co-author), 2015
  • “Auslizenzierungspraxis von Universitäten”, Platow Recht, Nr. 112, (co-author), 2014
  • “IP Flash – The new TTBER: Changes of Termination Clauses”, Euro Biotech News (co-author), 2014
  • “Die neue GVO-TT – Überblick und Auswirkungen, Technologietransfer”, transkript, (co-author), 2014
  • “Von „One-Size-fits-All“ zur maßgeschneiderten Therapie, Rechtliche Harmonisierungsbemühungen im Bereich der personalisierten Medizin”, GoingPublic Life Sciences, (co-author), 2014
  • “Fernabsatzverträge für Arzneimittel, Retoure: Verbraucherschutz vor Arzneimittelsicherheit? ”, transkript, Nr. 11, (co-author), 2013
  • “Das rechtliche Umfeld bei Companion Diagnostics”, Venture Capital, Sonderbeilage „Personalisierte Medizin“ (co-author), 2013

Interviews

  • “Changes to pricing rules instead of ending reimbursement for cannabis flowers“, Deutsche Apotheker Zeitung, July 2026
  • “Judith Heimbürger on regulatory uncertainty: Attractive cannabis market with a ‘noticeable risk discount’”, krautinvest.de, April 2026

Webinars, Panels and Keynotes

  • DEEP DIVE: “German Cannabis Regulation: GACP & GMP – Updates for Global Business”, Cannabis-Startups.com, Webinar, July 2026
  • “Tax Impact of Cannabis as Schedule III: Section 280E Relief, Transition Rules, European and German Markets”, BARBRI Webinar together with Patrick McCormick and Luke Engan, July 2026
  • “German Draft Bill Amending the MedCanG & Alternative Proposals (First Annual In Memoriam Peter Homberg Lecture)“, Presentation, Cannabis Symposium 2026 South Africa, June 2026
  • “Working As Independent Jurisdictions Needing Change in Brussels“, Cannabis Symposium 2026 South Africa, Panel, June 2026
  • DEEP DIVE: “Pre-Rolls, Vapes & Gummies – What Actually Works Under German Law?”, Cannabis-Startups.com, Webinar, June 2026
  • DEEP DIVE: “Behind the Label: GMP-Washing”, Cannabis-Startups.com, Webinar, May 2026
  • DEEP DIVE: “Cracking Germany: Latest Shifts & ICBC Insights for U.S. Cannabis Companies”, Cannabis-Startups.com, Webinar, April 2026
  • “Honoring Peter Homberg And Looking Toward The Future“, International Cannabis Business Conference (ICBC) Berlin, Presentation, April 2026
  • DEEP DIVE: “Two Years After the Introduction of the KCanG”, Webinar, March 2026
  • DEEP DIVE: “Advertising Medical Cannabis in Germany – Navigating the Regulatory Landscape of the HWG and BtMG”, Webinar, February 2026
  • DEEP DIVE: “Medical Cannabis at the Crossroads – What is next for 2026?”, Webinar, January 2026

 

 

 

Judith is a lawyer in gunnercooke GmbH, whose registered office is Kurfuerstendamm 15, 10719 Berlin, AG Charlottenburg, HRB 224488 B. All lawyers of gunnercooke GmbH are admitted either in Germany or Austria to practise as Rechtsanwalt or Rechtsanwaeltin and are members of and regulated by the relevant local Bar (Rechtsanwaltskammer).

Expertise

Back to top

Judith Heimbürger is an experienced lawyer specialising in advising clients in the life sciences sector.

She works with national and international companies as well as investors across pharmaceuticals, medical cannabis, medical devices, biotechnology and diagnostics, supporting them throughout the entire product and business development lifecycle.

Her clients particularly value her expertise in drafting and negotiating complex agreements, including cross-border supply and licensing arrangements (especially relating to patents and know-how), research and development agreements, collaboration and supply agreements, as well as contracts for clinical trials.

Judith also has significant experience advising on and leading cross-border M&A transactions, joint ventures and strategic partnerships in the life sciences sector. In addition, she advises on compliance matters, pharmaceutical advertising law, collaborations with physicians and pharmacists, and a wide range of regulatory issues relating to medical cannabis, medicinal products and medical devices.

A further key focus of her practice is legal advice in the field of medical cannabis, in particular CBD products – from regulatory matters and contract reviews through to M&A transactions.

Judith Advises

Back to top
  • National and international companies in the life sciences sector, from start-ups to listed
    companies, in particular in the fields of pharmaceuticals, diagnostics, medical devices and biotechnology as well as investors in this field
  • Pharmacists and doctors, in particular on professional law issues when practicing via online platforms

Experience Highlights

Back to top
  • High Tide Inc.: Comprehensive legal support on the signing of an investment agreement for the acquisition of a 51% stake in Remexian Pharma GmbH, one of Germany’s leading importers and wholesalers of medical cannabis.
  • German medium-sized API manufacturer: Legal advice and support in the negotiation of complex agreement structures, such as worldwide supply and license agreements with different partners
  • Canopy Growth Corp.: Advising a subsidiary of one of the leading Canadian medical cannabis suppliers on the acquisition of the German inhaler manufacturer Storz & Bickel GmbH & Co. KG for €135 million
  • Canadian medical cannabis supplier: Advising on the conclusion of a joint venture agreement with a German pharmaceutical wholesaler.
  • Large US medical devices manufacturer: Advising on CE marking, reclassification and other regulatory issues
  • Large US medical devices manufacturer: Advising on compliance issues in the context of clinical trials of medical devices.
  • International biotechnology company: Advising on several agreements (agreement on contract research, supply agreement)
  • German affiliate of a large international pharmaceutical company: Advising on various matters (e.g. supply and storage agreements)
  • A spin-off from a German university: Advising on various agreements (e.g., confidentiality and material transfer agreements, cooperation agreements) as well as issues concerning the German law on employees’ inventions
  • A German biotechnology company: Advising on a cooperation agreement concerning conducting a non-commercial clinical trial
  • Leading German medical cannabis manufacturer: Longstanding support in compliance and regulatory matters, contract reviews, as well as assessment of innovative business models, collaborations and marketing initiatives.

Career History

Back to top

Previous Experience

  • 10/2023–12/2024 (from 03/2023): Counsel, Dentons Europe (Germany) GmbH & Co. KG
  • 04/2015–09/2023: Senior Associate, Dentons Europe LLP
  • 08/2012–03/2015: Associate, Salans LLP, later Salans SNR Denton LLP
  • 02/2012–07/2012 (until and including 02/2013): Trainee, Salans LLP

Memberships

  • German Bar Association (Deutscher Anwaltsverein (DAV))
  • Frankfurt Bar Association (Frankfurter Anwaltsverein e.V.)
  • INCBA (International Cannabis Bar Association)

Education

  • University of Bayreuth (legal studies with an additional qualification in economics (Wirtschaftsjuristin (Univ. Bayreuth))
  • Qualification as Business Mediator (Wirtschaftsmediatorin (CVM))

Awards

Publications

  • “Market Access for North American Operators: Opportunities, Uncertainties and IP Protection“, The Legal Industry Reviews Germany, Vol.11 (author), June 2026
  • “Medical Cannabis at the Crossroads: Expecting a Major Setback for Digital Patient Care?“, The Legal Industry Reviews Germany, Vol.10 (author), March 2026
  • “Amendments to the MedCanG: The End of Telemedicine Platforms and Mail-Order Pharmacies?“, The Legal Industry Reviews Germany, Vol.9 (co-author), November 2025
  • “GMP-washing – A Harmless Loophole or an Underestimated Legal Risk?’, The Legal Industry Reviews Germany, Vol.8 (co-author), July 2025
  • “The ‘Second Pillar’ of Cannabis Legalization – A Mystery”, The Legal Industry Reviews Germany, Edition 7 (co-author), February 2025
  • “Current Case Law on Treatment Platforms for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 6 (co-author), November 2024
  • “Online Platforms for Medical Cannabis Treatment and Legal Pitfalls”, The Legal Industry Reviews Germany, Edition 4 (co-author), February 2024
  • “Draft Bill German Cannabis Law – Consequences for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 2 (co-author), September 2023
  • “Neuer Vorstoß zur Bekämpfung der Korruption im Gesundheitswesen”, Science4Life (co-author), 2015
  • “Auftragsforschung – Zu welchem Preis? ”, GoingPublic Magazin – Special “Biotechnologie” 2015 (co-author), 2015
  • “Bekämpfung von Korruption im Gesundheitswesen”, ZRFC 3/15, (co-author), 2015
  • “Auslizenzierungspraxis von Universitäten”, Platow Recht, Nr. 112, (co-author), 2014
  • “IP Flash – The new TTBER: Changes of Termination Clauses”, Euro Biotech News (co-author), 2014
  • “Die neue GVO-TT – Überblick und Auswirkungen, Technologietransfer”, transkript, (co-author), 2014
  • “Von „One-Size-fits-All“ zur maßgeschneiderten Therapie, Rechtliche Harmonisierungsbemühungen im Bereich der personalisierten Medizin”, GoingPublic Life Sciences, (co-author), 2014
  • “Fernabsatzverträge für Arzneimittel, Retoure: Verbraucherschutz vor Arzneimittelsicherheit? ”, transkript, Nr. 11, (co-author), 2013
  • “Das rechtliche Umfeld bei Companion Diagnostics”, Venture Capital, Sonderbeilage „Personalisierte Medizin“ (co-author), 2013

Interviews

  • “Changes to pricing rules instead of ending reimbursement for cannabis flowers“, Deutsche Apotheker Zeitung, July 2026
  • “Judith Heimbürger on regulatory uncertainty: Attractive cannabis market with a ‘noticeable risk discount’”, krautinvest.de, April 2026

Webinars, Panels and Keynotes

  • DEEP DIVE: “German Cannabis Regulation: GACP & GMP – Updates for Global Business”, Cannabis-Startups.com, Webinar, July 2026
  • “Tax Impact of Cannabis as Schedule III: Section 280E Relief, Transition Rules, European and German Markets”, BARBRI Webinar together with Patrick McCormick and Luke Engan, July 2026
  • “German Draft Bill Amending the MedCanG & Alternative Proposals (First Annual In Memoriam Peter Homberg Lecture)“, Presentation, Cannabis Symposium 2026 South Africa, June 2026
  • “Working As Independent Jurisdictions Needing Change in Brussels“, Cannabis Symposium 2026 South Africa, Panel, June 2026
  • DEEP DIVE: “Pre-Rolls, Vapes & Gummies – What Actually Works Under German Law?”, Cannabis-Startups.com, Webinar, June 2026
  • DEEP DIVE: “Behind the Label: GMP-Washing”, Cannabis-Startups.com, Webinar, May 2026
  • DEEP DIVE: “Cracking Germany: Latest Shifts & ICBC Insights for U.S. Cannabis Companies”, Cannabis-Startups.com, Webinar, April 2026
  • “Honoring Peter Homberg And Looking Toward The Future“, International Cannabis Business Conference (ICBC) Berlin, Presentation, April 2026
  • DEEP DIVE: “Two Years After the Introduction of the KCanG”, Webinar, March 2026
  • DEEP DIVE: “Advertising Medical Cannabis in Germany – Navigating the Regulatory Landscape of the HWG and BtMG”, Webinar, February 2026
  • DEEP DIVE: “Medical Cannabis at the Crossroads – What is next for 2026?”, Webinar, January 2026

Back to top

 

 

 

Judith is a lawyer in gunnercooke GmbH, whose registered office is Kurfuerstendamm 15, 10719 Berlin, AG Charlottenburg, HRB 224488 B. All lawyers of gunnercooke GmbH are admitted either in Germany or Austria to practise as Rechtsanwalt or Rechtsanwaeltin and are members of and regulated by the relevant local Bar (Rechtsanwaltskammer).

News and Insights from our Partners

Go to Reading room >